allopurinol-ratiopharm tablett
merckle gmbh - allopurinool - tablett - 300mg 50tk
allopurinol tablett
takeda gmbh - allopurinool - tablett - 100mg 100tk
aerinaze
n.v. organon - desloratadine, pseudophedrine sulfate - riniit, allergiline, hooajaline - nina preparaadid - hooajalise allergilise riniidi sümptomaatiline ravi, kui sellega kaasneb ninakinnisus.
emadine
immedica pharma ab - emedastine difumarate - konjunktiviit, allergiline - oftalmoloogilised vahendid - hooajalise allergilise konjunktiviidi sümptomaatiline ravi.
opatanol
novartis europharm limited - olopatadiinvesinikkloriid - konjunktiviit, allergiline - oftalmoloogilised vahendid - hooajalise allergilise konjunktiviidi silmahaiguste ja sümptomite ravi.
desloratadine actavis
actavis group ptc ehf - desloratadiin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistamiinid süsteemseks kasutuseks, - allergilise riniidi ja urtikaaria ravi.
xolair
novartis europharm limited - omalizumab - asthma; urticaria - ravimid hingamisteede obstruktiivsete haiguste, - allergiline asthmaxolair on näidustatud täiskasvanud, noorukid ja lapsed (6 kuni.
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lümfoom, mantle-cell - antineoplastilised ained - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).